MET and neoplasm: Association with clinical and pathological features in primary tumor, MET copy number gains in the context of metastatic spread and initial in-vitro data indicating that MET-signaling acts as mediator of antiangiogenic therapy [46], suggest a biologic relevance of MET signaling in ccRCCs.